Notably, tumor cells can utilize the PD1/PDL1 pathway to circumvent the immune surveillance by expression of PDL1 [32], and in human glioma, PDL1 was found to be a negative prognostic indicator [46]. This evidence concerns the gene CD274 and neoplasm.